The Lancet Diabetes & Endocrinology

Insulin thermostability in a real-world setting.

Pendsey S, James S, Garrett TJ, ..., Forsander G, Ogle GD

The Lancet Diabetes & Endocrinology 11 (5) 310-312 [2023-05-00; online 2023-03-29]

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.

Dawed AY, Mari A, Brown A, ..., Pearson ER, DIRECT consortium

The Lancet Diabetes & Endocrinology 11 (1) 33-41 [2023-01-00; online 2022-12-18]

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.

Schmidt AF, Swerdlow DI, Holmes MV, ..., UCLEB consortium , Sattar N

The Lancet Diabetes & Endocrinology 5 (2) 97-105 [2017-02-00; online 2016-11-29]

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.

Hallberg P, Eriksson N, Ibañez L, ..., Wadelius M, EuDAC collaborators

The Lancet Diabetes & Endocrinology 4 (6) 507-516 [2016-06-00; online 2016-05-03]

Use of type 2 diabetes risk scores in clinical practice: a call for action.

Nowak C, Ingelsson E, Fall T

The Lancet Diabetes & Endocrinology 3 (3) 166-167 [2015-03-00; online 2015-01-28]

Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study.

Vimaleswaran KS, Cavadino A, Berry DJ, ..., Järvelin MR, Hyppönen E

The Lancet Diabetes & Endocrinology 2 (9) 719-729 [2014-09-00; online 2014-06-25]